Intellia Therapeutics, Inc. (NTLA) Profit Margins
Over the twelve months to 2026-06-30, Intellia Therapeutics, Inc. (NTLA) had operating margin -711.7%, net margin -672.2%, free cash flow margin -586.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NTLAIntellia Therapeutics, Inc.Follow NTLA — free
—
Price chart with a free account
- Market cap
- 1.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | — | — | — | — | — | |
| Operating margin | -298.6% | -246.8% | -235.5% | -810.4% | -879.0% | -1420.5% | -923.1% | -651.7% | -711.7% | |
| Net margin | -280.4% | -1100.1% | -231.5% | -810.5% | -909.8% | -1326.5% | -896.8% | -609.9% | -672.2% | |
| FCF margin | -222.2% | -255.3% | -92.2% | -719.4% | -665.5% | -1124.9% | -612.8% | -585.0% | -586.0% |
USD billions · SEC XBRL
Intellia Therapeutics, Inc. — questions
- What is Intellia Therapeutics, Inc.'s operating margin?
- -711.7% over the twelve months to 2026-06-30.
- What is Intellia Therapeutics, Inc.'s net profit margin?
- -672.2% over the twelve months to 2026-06-30.
Every figure on this page comes from Intellia Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.